AKBA
Akebia Therapeutics Inc
Price:  
1.47 
USD
Volume:  
3,010,500.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AKBA Probability of Bankruptcy

The Probability of Bankruptcy of Akebia Therapeutics Inc (AKBA) is 75.78% . This number represents the probability that AKBA will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating AKBA's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

AKBA - ESG ratings

ESG ratings are directly linked to the cost of capital and AKBA's ability to raise funding, both of which can significantly affect the probability of Akebia Therapeutics Inc going bankrupt.

ESG Score 72.50
Environment Score 75.70
Social Score 99.00
Governance Score 42.80
Returns
Historical Returns (5 day) 8.09%
Historical Returns (MTD) 44.12%
Historical Returns (YTD) 18.55%
Historical Returns (13 week) 8.09%
Historical Returns (26 week) 5.00%
Historical Returns (52 week) -%
Efficiency
Asset Turnover 0.78
Receiveable Turnover 8.43
Gross Margin 91.70%
Operating Margin -47.39%
Pretax Margin -55.16%
Net Margin -55.16%
Return on Asset (ROA) -18.02
Return on Equity (ROE) -362.42
Return on Investments (ROI) -89.46
Price Metrics
Market Cap (M) 308.11
Enterprise Value (M)
52 Week High 2.47
52 Week Low 0.79
Beta 1.69
Average Volume (10 day) 0.60
Average Volume (3 month) 0.98
Price / Earnings (P/E)
Price / Sales (P/S) 1.62
Earnings
EPS -0.22
Revenue CAGR (5 year) -1.29%
Risk
Current Ratio 1.70
Quick Ratio 1.03